Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer
2016 · EBioMedicine · 51 citations
https://doi.org/10.1016/j.ebiom.2016.08.016
W
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
1.6K
Citations
18
h-index
21
i10-index
Weige Tan is an academic researcher from First Affiliated Hospital of Guangzhou Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer Cells and Metastasis & Cancer-related molecular mechanisms research. The author has an h-index of 18, co-authored 28 publications.
ORCID: 0000-0001-8633-1692Papers by this author
worksPreoperative prediction nomogram based on primary tumor miRNAs signature and clinical‐related features for axillary lymph node metastasis in early‐stage invasive breast cancer
2017 · International Journal of Cancer · 48 citations
https://doi.org/10.1002/ijc.31208
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer
2024 · Cell Death Discovery · 36 citations
https://doi.org/10.1038/s41420-023-01771-w
Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial
2025 · BMJ · 0 citations
https://doi.org/10.1136/bmj-2025-084290
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat